CHWY vs ZVRA · P/E 45, rev $12.60B vs P/E 6.3, rev $75.9M
Chewy Inc (CHWY) versus Zevra Therapeutics Inc. (ZVRA) — a side-by-side from cached financials, not a winner call.
Chewy Inc (CHWY) is a internet retail company listed on US.
Zevra Therapeutics Inc. (ZVRA) is a biotechnology company listed on NASDAQ.
Latest reported CHWY revenue for 2026-02-01 was $12.60B. Net income was $222.8M. Revenue was up 6.2% from 2025-02-02 to 2026-02-01. CHWY currently screens at market cap $16.92B and trailing P/E 45.0.
Latest reported ZVRA revenue for 2026-06-30 was $75.9M. Net income was $46.6M. ZVRA currently screens at market cap $745.4M and trailing P/E 6.3.
CHWY currently screens at market cap $16.92B and trailing P/E 45.0. ZVRA currently screens at market cap $745.4M and trailing P/E 6.3.
Not investment advice. Open the CHWY and ZVRA stock pages for the full models.
Not investment advice.